Zusammenfassung
Das typische Bild der Akanthamöbenkeratitis zeichnet sich durch pseudodendritiforme Epitheliopathie, Perineuritis, Ringinfiltrat oder multifokale stromale Infiltrate aus. Jedoch können auch eine Limbitis mit Infiltration der Konjunktiva oder eine Uveitis anterior auftreten. Etwa 83–93 % der Patienten mit Akanthamöbenkeratitis sind Kontaktlinsenträger. Die Diagnosestellung einer Akanthamöbeninfektion erfolgt anhand von Polymerasekettenreaktion (PCR), konfokaler Biomikroskopie, In-vitro-Kultivierung oder histopathologischen Untersuchungen. Bisher liegen keine randomisierten kontrollierten klinischen Studien vor, daher stammen die Informationen über Effektivität und Sicherheit der medikamentösen und chirurgischen Therapie nur aus publizierten Fallserien. Es wird eine 3-fache medikamentöse Therapie aus Polyhexamid, Propamidinisoethionat und Neomycin zur Behandlung empfohlen, die bis zu einem Jahr angewendet werden sollte. Bei Therapieresistenz kann eine Kryotherapie, Amnionmembrantransplantation, Crosslinkingtherapie oder eine therapeutische Keratoplastik notwendig werden. Bestanden 3 Monate lang vor einer geplanten Keratoplastik keine Infektionszeichen mehr, ist die Prognose am besten.
Abstract
The typical clinical appearance of acanthamoeba keratitis includes pseudodendritic epitheliopathy, perineuritis, ring infiltrates or multifocal stromal infiltrates and in some cases limbitis with infiltration of the conjunctiva and/or sterile anterior uveitis. In 83–93 % of cases of acanthamoeba keratitis the patients were contact lens wearers. Acanthamoeba keratitis is diagnosed by polymerase chain reaction (PCR), confocal biomicroscopy, in vitro cultivation and histopathological examination. Information on reliability and efficacy of conservative and surgical therapy of acanthamoeba keratitis has only been published in case series but not yet verified through randomized controlled clinical studies. After early diagnosis acanthamoeba keratitis can often be successfully treated using triple topical therapy with polyhexamide, propamidine isethionate and neomycin. Topical therapy should be continued for up to 1 year. In therapy-resistant cases cryotherapy, amniotic membrane transplantation, crosslinking therapy and therapeutic keratoplasty can be performed. The prognosis of keratoplasty following acanthamoeba keratitis is more favorable if there were no signs of infection at least 3 months before surgery.
Literatur
Meltendorf C, Duncker G (2011) Akanthamöben-Keratitis. Klin Monatsbl Augenheilkd 228:R29–R43
Szentmáry N, Göbels S, Matoula P et al (2012) Die Akanthamöbenkeratitis – ein seltenes und oft spät diagnostiziertes Chamäleon. Klin Monatsbl Augenheilkd 229:521–528
Panjwani N (2010) Pathogenesis of Acanthamoeba keratitis. Ocul Surf 8:70–79
Hadas E, Mazur T (1993) Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. Trop Med Parasitol 44:197–200
Moore MB, McCulley JP, Kaufman HE, Robin JB (1986) Radial keratoneuritis as a presenting sign in Acanthamoeba keratitis. Ophthalmology 93:1310–1315
Weekers PH, Bodelier PL, Wijen JP et al (1993) Effects of grazing by the free-living soil amoebae Acanthamoeba castellanii, Acanthamoeba polyphaga, and Hartmannella vermiformis on various bacteria. Appl Environ Microbiol 59:2317–2319
Gupta S, Das SR (1999) Stock cultures of free-living amebas: effect of temperature on viability and pathogenicity. J Parasitol 85:137–139
Aksozek A, McClellan K, Howard K et al (2002) Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol 88:621–623
Mazur T, Hadas E, Iwanicka I (1995) The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol 46:106–108
Pussard M, Pons R (1977) Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 13:557–610
Stothard DR, Hay J, Schroeder-Diedrich JM et al (1999) Fluorescent oligonucleotide probes for clinical and environmental detection of Acanthamoeba and the T4 18S rRNA gene sequence type. J Clin Microbiol 37:2687–2693
Naginton J, Watson PG, Playfair TJ et al (1974) Amoebic infection of the eye. Lancet 2:1537–1540
Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10
Seal DV (2003) Acanthamoeba keratitis update – incidence, molecular epidemiology and new drugs for treatment. Eye (Lond) 17:893–905
Acharya NR, Lietman TM, Margolis TP (2007) Parasites on the rise: a new epidemic of Acanthamoeba keratitis. Am J Ophthalmol 144:292–293
Carvalho FR, Foronda AS, Mannis MJ et al (2009) Twenty years of Acanthamoeba keratitis. Cornea 28:516–519
Radford CF, Lehmann OJ, Dart JK (1998) National Acanthamoeba Keratitis Study Group. Acanthamoeba keratitis: multicentre survey in England 1992–6. Br J Ophthalmol 82:1387–1392
Watt K, Swarbrick HA (2005) Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 31:201–208
Hammersmith KM (2006) Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 17:327–331
Johnston SP, Sriram R, Qvarnstrom Y et al (2009) Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions. J Clin Microbiol 47:2040–2045
Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108
Dart JK, Saw VP, Kilvington S (2009) Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 148:487–499
Reinhard T, Behrens-Baumann W (2006) Anti-infective drug therapy in ophthalmology – part 4: Acanthamoeba keratitis. Klin Monatsbl Augenheilkd 223:485–492
Pfister DR, Cameron JD, Krachmer JH et al (1996) Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol 121:119–128
Mathers WD, Sutphin JE, Folberg R et al (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129–142
Aspöck H (2006) Grundzüge der Diagnostik. In: Hiepe T, Lucius R, Gottstein B (Hrsg) Allgemeine Parasitologie mit den Grundzügen der Immunologie, Diagnostik und Bekämpfung. Parey in MVS Medizinverlage, Stuttgart, S 477
Sharma S, Athmanathan S, Atha-Ur-Rasheed M et al (2001) Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Indian J Ophthalmol 49:181–186
Claerhout I, Goegebuer A, Van Den Broecke C et al (2004) Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol 242:648–653
Awwad ST, Petroll WM, McCulley JP et al (2007) Updates in Acanthamoeba keratitis. Eye Contact Lens 33:1–8
Perry HD, Donnenfeld ED, Foulks GN et al (1995) Decreased corneal sensation as an initial feature of Acanthamoeba keratitis. Ophthalmology 102:1565–1568
Papathanassiou M, Gartry D (2007) Steril corneal ulcer with ring infiltrate and hypopyon after recurrent erosions. Eye 21:124–126
Patel DV, McGhee CN (2009) Acanthamoeba keratitis: a comprehensive photographic reference of common and uncommon signs. Clin Experiment Ophthalmol 37:232–238
Kremer I, Cohen EJ, Eagle RC Jr et al (1994) Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 20:45–48
Clarke DW, Alizadeh H, Niederkorn JY (2005) Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci 46:2472–2478
Herz NL, Matoba AY, Wilhelmus KR (2008) Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology 115:866–869
Kelley PS, Dossey AP, Patel D et al (2006) Secondary glaucoma associated with advanced acanthamoeba keratitis. Eye Contact Lens 32:178–182
Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185–191
Ficker L, Seal D, Warhurst D et al (1990) Acanthamoeba keratitis – resistance to medical therapy. Eye (Lond) 4(Pt 6):835–838
Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69:778–782
Elder MJ, Kilvington S, Dart JK (1994) A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 35:1059–1064
McClellan K, Howard K, Niederkorn JY et al (2001) Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 42:2885–2893
D’Aversa G, Stern GA, Driebe WT Jr (1995) Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 113:1120–1123
Amoils SP, Heney C (1999) Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol 127:718–720
Oldenburg CE, Acharya NR, Tu EZ et al (2011) Practice patterns and opinions in the treatment of acanthamoeba keratitis. Cornea 30:1363–1368
Brooks JG Jr, Coster DJ, Badenoch PR (1994) Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea 13:186–189
Szentmáry N, Goebels S, Bischoff M, Seitz B (2012) Photodynamische Therapie (PDT) bei infektiöser Keratitis. Ophthalmologe 109:165–170
Khan YA, Kashiwabuchi RT, Martins SA et al (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeben keratitis: report of 3 cases. Ophthalmology 118:324–331
Kitzmann AS, Goins KM, Sutphin JE et al (2009) Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 116:864–869
Seitz B, Langenbucher A, Kuss MM et al (1999) Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology 106(6):1556–1564
Szentmáry N, Langenbucher A, Kus MM et al (2007) Elliptical nonmechanical corneal trephination – Intraoperative complications and long-term outcome of 42 consecutive penetrating keratoplasties. Cornea 26:414–420
Einhaltung ethischer Richtlinien
Interessenkonflikt. N. Szentmáry, L. Daas, P. Matoula, S. Goebels und B. Seitz geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Szentmáry, N., Daas, L., Matoula, P. et al. Akanthamöbenkeratitis. Ophthalmologe 110, 1203–1211 (2013). https://doi.org/10.1007/s00347-013-2981-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-013-2981-0